
About Us
Leukaemia & Lymphoma NI is the only charity in Northern Ireland dedicated to blood cancer research. Our mission is to improve survival rates and quality of life for all blood cancer patients by supporting clinicians, scientists and students researching these diseases.
Leukaemia & Lymphoma NI formerly known as the Northern Ireland Leukaemia Research Fund was founded by the McDowell family in 1964 following the death of their daughter Carole. In an effort to prevent other families suffering this loss, the McDowell’s started fundraising for blood cancer research and the Northern Ireland Leukaemia Research Fund was born.
The charity is the McDowell family legacy, their determination to do something for others when faced with terrible circumstances still drives much of the work we do today.
Team Members

Joanne Badger
Operations Manager

Claire Gilmore
Administration Manager

Collette McMorrow
Donor Relations Manager
The Board

Richard Buchanan
Chairman

David Montgomery

Brigid Napier

Professor Terry Lappin

Professor Curly Morris

Leanne Cascone

Brendan Kearney

Rob Cascone

Graham Coulter
Annual Trustees Reports
- Leukaemia & Lymphoma NI Report & Financial Statement Year End 2017
- Leukaemia & Lymphoma NI Report & Financial Statement Year End 2018
- Leukaemia & Lymphoma NI Report & Financial Statement Year End 2019
- Leukaemia & Lymphoma NI Report & Financial Statement Year End 2020
Scientific and Medical Committee
The Scientific and Medical Committee is a panel of independent researchers and clinicians who provide recommendations to Leukaemia & Lymphoma NI on decisions relating to the funding and management of research projects.
They ensure that all LLNI funding awards support the highest quality research and will consider applications for funding for basic, translational and clinical related research.
Current Members:
Professor Patrick Morrison – Chair
Dr Lynn McCallum
Dr Brídgín Merron
Dr Glenda Joanne Dickson
Dr Aaron Niblock
Scientific and Medical Committee Terms of Reference
Leukaemia & Lymphoma NI Conflicts of Interest Policy